Hemogenyx Pharmaceuticals (HEMO) Stock Chart & Stock Price History GBX 317.50 +14.00 (+4.61%) As of 02/21/2025 12:51 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlines Hemogenyx Pharmaceuticals Stock Price Performance 5 Day Performance-5.29%1 Month Performance-14.13%3 Month Performance+26,358.33%6 Month Performance+24,323.08%Year-To-Date Performance-21.02%1 Year Performance+10,141.94% Receive HEMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address HEMO Stock Chart for Saturday, February, 22, 2025 HEMO Chart by TradingView Hemogenyx Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025GBX 303.50GBX 317.50+4.61%GBX 320GBX 303.6031,809 shs£11.32 million02/20/2025GBX 281GBX 303.50+8.01%GBX 309.12GBX 296.60103,799 shs£10.82 million02/19/2025GBX 322.75GBX 281-12.94%GBX 324GBX 271.5083,679 shs£10.02 million02/18/2025GBX 335.23GBX 322.75-3.72%GBX 349GBX 31025,896 shs£11.50 million02/17/2025GBX 327.23GBX 335.23+2.45%GBX 349GBX 327.151,645 shs£11.95 million02/14/2025GBX 333GBX 327.23-1.73%GBX 350GBX 32511,026 shs£11.66 million02/13/2025GBX 326GBX 333+2.15%GBX 333.83GBX 329.0518,784 shs£11.87 million02/12/2025GBX 335.60GBX 326-2.86%GBX 349GBX 32635,133 shs£4.37 billion02/11/2025GBX 340GBX 335.60-1.29%GBX 349GBX 331.903,943 shs£4.50 billion02/10/2025GBX 343GBX 340-0.87%GBX 359GBX 3306,823 shs£4.56 billion Get the Latest News and Ratings for HEMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025GBX 340GBX 343+0.88%GBX 359GBX 3362,071 shs£4.60 billion02/06/2025GBX 344GBX 340-1.16%GBX 354GBX 330.728,499 shs£4.56 billion02/05/2025GBX 342.60GBX 344+0.41%GBX 354GBX 331.2010,987 shs£4.61 billion02/04/2025GBX 340.70GBX 342.60+0.56%GBX 354GBX 3354,641 shs£4.59 billion02/03/2025GBX 362GBX 340.70-5.88%GBX 369GBX 337.1015,919 shs£4.57 billion01/31/2025GBX 363GBX 362-0.28%GBX 369GBX 35119,814 shs£4.85 billion01/30/2025GBX 363.80GBX 363-0.22%GBX 369GBX 355.2527,271 shs£4.86 billion01/29/2025GBX 363.35GBX 363.80+0.12%GBX 370GBX 351.9011,207 shs£4.87 billion01/28/2025GBX 373GBX 363.35-2.59%GBX 363.35GBX 35131,543 shs£4.87 billion01/27/2025GBX 374GBX 373-0.27%GBX 385GBX 3565,144 shs£5.00 billion01/24/2025GBX 365.10GBX 374+2.44%GBX 385GBX 355.102,233 shs£5.01 billion01/23/2025GBX 369.75GBX 365.10-1.26%GBX 377.11GBX 355.1011,137 shs£4.89 billion01/22/2025GBX 373GBX 369.75-0.87%GBX 373.91GBX 3552,715 shs£4.95 billion01/21/2025GBX 350GBX 373+6.57%GBX 374.90GBX 350.103,838 shs£5.00 billion Related Companies Ondine Biomedical Stock Price Chart Oxford Nanopore Technologies Stock Price Chart Genus Stock Price Chart Oxford Biomedica Stock Price Chart PureTech Health Stock Price Chart Faron Pharmaceuticals Oy Stock Price Chart Avacta Group Stock Price Chart Bioventix Stock Price Chart 4basebio Stock Price Chart hVIVO Stock Price Chart Receive HEMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:HEMO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemogenyx Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemogenyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
